2016
DOI: 10.1016/j.lfs.2016.09.002
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of in vivo estrogenic potency of natural estrogen-active chemical, puerarin, on pituitary function in gonadectomized female rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
7
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(8 citation statements)
references
References 48 publications
1
7
0
Order By: Relevance
“…In the present study, both 17β-estradiol (2) and puerarin (1), at high doses, were found to significantly increase uterine weights and volumes in OVX animals, suggesting that puerarin (2) exhibits estrogenic-like activity, in a similar manner to 17β-estradiol (2). Our finding is in agreement with the previous reports which demonstrated that puerarin (2) exerted uterotrophic effects in OVX mice after long-term treatment [19,20]. Moreover, in the MCF-7 cell proliferation assay, puerarin (2) was found to bind to both estrogen receptors (ERs) and exhibited estrogenic activity [21].…”
Section: Discussionsupporting
confidence: 93%
“…In the present study, both 17β-estradiol (2) and puerarin (1), at high doses, were found to significantly increase uterine weights and volumes in OVX animals, suggesting that puerarin (2) exhibits estrogenic-like activity, in a similar manner to 17β-estradiol (2). Our finding is in agreement with the previous reports which demonstrated that puerarin (2) exerted uterotrophic effects in OVX mice after long-term treatment [19,20]. Moreover, in the MCF-7 cell proliferation assay, puerarin (2) was found to bind to both estrogen receptors (ERs) and exhibited estrogenic activity [21].…”
Section: Discussionsupporting
confidence: 93%
“…We subsequently examined how puerarin induced SUMO2 expression and protected cardiomyocytes against hypoxia/reoxygenation challenge. Like many other naturally occurring flavonoids, puerarin is classified as an estrogen receptor modulator and predominantly exhibits estrogenic activity for health benefits ( Loutchanwoot et al, 2016 ; Hou et al, 2021 ). Figure 5 showed that puerarin was well bound to ER protein with the binding energy of −7.3 kcal/mol and induced the expression of reporter luciferase through an ER-mediated mechanism.…”
Section: Discussionmentioning
confidence: 99%
“…Also, 17β-estradiol has been recognized as an inhibitor of IDD by downregulating MMP-3 and MMP-13 and upregulating type II collagen [20]. Similarly, though PUR has not been reported yet in treating IDD, this medicine, as a phytoestrogen [21], is likely to be potentially favorable in suppression of IDD. To be more specific, PUR is greatly associated with modification of autophagy [22], decreased reactive oxygen species (ROS) production [23], and anti-inflammation effects [23].…”
Section: Introductionmentioning
confidence: 99%